This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

JAMA. 2000;284:2714-2715.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MMWR. 2000;49:1001-1003

1 table omitted

Declines in cervical cancer incidence and mortality reported in the United States since the 1950s have been attributed to early detection and treatment of precancerous and cancerous lesions through the use of the Papanicolaou (Pap) test.¹ More than 50 million Pap tests are performed each year²; however, guidelines about the frequency of testing in women with a history of normal test results are inconsistent.^3-5 To determine the incidence of cervical cytologic abnormalities following a normal Pap test, 1991-1998 data from the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) were analyzed for this report.⁶ The findings indicated that within 3 years of a normal Pap test result, severe cytologic abnormalities were uncommon, and incidence rates were similar among women screened 1, 2, and 3 years following a normal Pap test.

For each woman, CDC received a report that included demographic characteristics, Pap test . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?